Cargando…

Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study

The Centers for Disease Control and Prevention provides biomonitoring data in the United States as part of the National Health and Nutrition Examination Survey (NHANES). Recently, Statistics Canada initiated a similar survey — the Canadian Health Measures Survey (CHMS). Comparison of US and Canadian...

Descripción completa

Detalles Bibliográficos
Autores principales: LaKind, Judy S, Levesque, Johanne, Dumas, Pierre, Bryan, Shirley, Clarke, Janine, Naiman, Daniel Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331622/
https://www.ncbi.nlm.nih.gov/pubmed/22333730
http://dx.doi.org/10.1038/jes.2012.1
_version_ 1782230132616855552
author LaKind, Judy S
Levesque, Johanne
Dumas, Pierre
Bryan, Shirley
Clarke, Janine
Naiman, Daniel Q
author_facet LaKind, Judy S
Levesque, Johanne
Dumas, Pierre
Bryan, Shirley
Clarke, Janine
Naiman, Daniel Q
author_sort LaKind, Judy S
collection PubMed
description The Centers for Disease Control and Prevention provides biomonitoring data in the United States as part of the National Health and Nutrition Examination Survey (NHANES). Recently, Statistics Canada initiated a similar survey — the Canadian Health Measures Survey (CHMS). Comparison of US and Canadian biomonitoring data can generate hypotheses regarding human exposures from environmental media and consumer products. To ensure that such comparisons are scientifically meaningful, it is essential to first evaluate aspects of the surveys' methods that can impact comparability of data. We examined CHMS and NHANES methodologies, using bisphenol A (BPA) as a case study, to evaluate whether survey differences exist that would hinder our ability to compare chemical concentrations between countries. We explored methods associated with participant selection, urine sampling, and analytical methods. BPA intakes were also estimated to address body weight differences between countries. Differences in survey methods were identified but are unlikely to have substantial impacts on inter-survey comparisons of BPA intakes. BPA intakes for both countries are below health-based guidance values set by the US, Canada and the European Food Safety Authority. We recommend that before comparing biomonitoring data between surveys, a thorough review of methodologic aspects that might impact biomonitoring results be conducted.
format Online
Article
Text
id pubmed-3331622
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-33316222012-04-20 Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study LaKind, Judy S Levesque, Johanne Dumas, Pierre Bryan, Shirley Clarke, Janine Naiman, Daniel Q J Expo Sci Environ Epidemiol Original Article The Centers for Disease Control and Prevention provides biomonitoring data in the United States as part of the National Health and Nutrition Examination Survey (NHANES). Recently, Statistics Canada initiated a similar survey — the Canadian Health Measures Survey (CHMS). Comparison of US and Canadian biomonitoring data can generate hypotheses regarding human exposures from environmental media and consumer products. To ensure that such comparisons are scientifically meaningful, it is essential to first evaluate aspects of the surveys' methods that can impact comparability of data. We examined CHMS and NHANES methodologies, using bisphenol A (BPA) as a case study, to evaluate whether survey differences exist that would hinder our ability to compare chemical concentrations between countries. We explored methods associated with participant selection, urine sampling, and analytical methods. BPA intakes were also estimated to address body weight differences between countries. Differences in survey methods were identified but are unlikely to have substantial impacts on inter-survey comparisons of BPA intakes. BPA intakes for both countries are below health-based guidance values set by the US, Canada and the European Food Safety Authority. We recommend that before comparing biomonitoring data between surveys, a thorough review of methodologic aspects that might impact biomonitoring results be conducted. Nature Publishing Group 2012-05 2012-02-15 /pmc/articles/PMC3331622/ /pubmed/22333730 http://dx.doi.org/10.1038/jes.2012.1 Text en Copyright © 2012 Nature America, Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
LaKind, Judy S
Levesque, Johanne
Dumas, Pierre
Bryan, Shirley
Clarke, Janine
Naiman, Daniel Q
Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
title Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
title_full Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
title_fullStr Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
title_full_unstemmed Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
title_short Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
title_sort comparing united states and canadian population exposures from national biomonitoring surveys: bisphenol a intake as a case study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331622/
https://www.ncbi.nlm.nih.gov/pubmed/22333730
http://dx.doi.org/10.1038/jes.2012.1
work_keys_str_mv AT lakindjudys comparingunitedstatesandcanadianpopulationexposuresfromnationalbiomonitoringsurveysbisphenolaintakeasacasestudy
AT levesquejohanne comparingunitedstatesandcanadianpopulationexposuresfromnationalbiomonitoringsurveysbisphenolaintakeasacasestudy
AT dumaspierre comparingunitedstatesandcanadianpopulationexposuresfromnationalbiomonitoringsurveysbisphenolaintakeasacasestudy
AT bryanshirley comparingunitedstatesandcanadianpopulationexposuresfromnationalbiomonitoringsurveysbisphenolaintakeasacasestudy
AT clarkejanine comparingunitedstatesandcanadianpopulationexposuresfromnationalbiomonitoringsurveysbisphenolaintakeasacasestudy
AT naimandanielq comparingunitedstatesandcanadianpopulationexposuresfromnationalbiomonitoringsurveysbisphenolaintakeasacasestudy